Long-Term Survival Rates and Treatment Trends of Burkitt Lymphoma in Patients with HIV-A National Cancer Database (NCDB) Study.
Clare M WielandAshley M TuinElizabeth J DortAlexander G HallMridula KrishnanManasa VelagapudiPublished in: Cancers (2024)
There is an increased mortality rate from months 3 to 60 in BL patients with HIV compared to patients without HIV. Additionally, risk of death in the first 3 months is significantly decreased by 45% in patients with HIV treated with combination chemotherapy and immunotherapy compared to patients without HIV receiving combination chemotherapy and immunotherapy, providing valuable clinical insight into treatment decision making in the care of HIV-associated BL.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- hepatitis c virus
- hiv aids
- men who have sex with men
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- south africa
- prognostic factors
- peritoneal dialysis
- type diabetes
- squamous cell carcinoma
- emergency department
- coronary artery disease
- palliative care
- health insurance
- replacement therapy
- rectal cancer
- smoking cessation